Acquisition in Medica TS Hospital Pvt Ltd

Summary by AI ^BETAClose X

Tata Steel Limited has completed the acquisition of the entire stake in Medica TS Hospital Private Limited for an aggregate consideration of ₹1.49 crore, acquiring 7,40,000 equity shares representing a 49% equity stake and 2,30,05,182 optionally convertible redeemable preference shares representing a 31.85% preference share stake. Following this transaction, Medica TS Hospital is now a wholly owned subsidiary of Tata Steel Limited.

Disclaimer*

Tata Steel Limited

30 March 2026

Ref: SEC/2226/2025-26

March 30, 2026

London Stock Exchange

London

Dear Madam, Sirs,

Sub: Acquisition of entire stake in Medica TS Hospital Private Limited

This is further to our disclosure dated March 17, 2026 on the abovementioned subject.

This is to inform you that, Tata Steel Limited ('Company') has today i.e. on March 30, 2026, completed the acquisition of the following securities in Medica TS Hospital Private Limited ('Medica TS Hospital'), a subsidiary company, from Manipal Hospitals Eastern India Private Limited (formerly known as Medica Hospitals Private Limited), as per the terms and conditions of the Share Purchase Agreement executed on March 17, 2026, for an aggregate consideration of ₹1.49 crore:

a) 7,40,000 equity shares of face value ₹10/- each, constituting 49% equity stake in Medica TS Hospital; and

b) 2,30,05,182, - 0.01% Optionally Convertible Redeemable Preference Shares ('OCRPS') constituting 31.85% of preference share stake of Medica TS Hospital.

On completion of the aforesaid acquisition, Tata Steel Limited holds 100% stake in equity shareholding and in OCRPS of Medica TS Hospital. Medica TS Hospital has become a wholly owned subsidiary of the Company.

This disclosure is being made by the Company in compliance with Regulations 30 and 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

This is for your information and records.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END